Market Place
Sourcing Support
All News #Library
Qilu’s Generics Sugammadex Receives Tentative Approval in US
15 Apr 2026 //
FDA
Qilu’s Generics Revefenacin Receives Tentative Approval in US
23 Mar 2026 //
FDA
Qilu’s Generics Nintedanib Receives Tentative Approval in US
17 Mar 2026 //
FDA
Qilu Pharm’s Generics Doxorubicin HCl Receives Approval in US
03 Feb 2026 //
FDA
Qilu’s Generics Abemaciclib Receives Tentative Approval In US
06 Nov 2025 //
FDA
Qilu Pharm’s Generics Afatinib Receives Tentative Approval in US
08 Oct 2025 //
FDA
Qilu`s Generics Cyclosporine Receives Approval in US
15 Sep 2025 //
FDA
Qilu’s Generics Mirabegron Receives Approval in US
30 Jun 2025 //
FDA
Qilu Pharma`s Generics Olanzapine Receives Approval in US
16 May 2025 //
FDA
Qilu Pharma`s Generics Icosapent Ethyl Receives Approval in US
20 Nov 2024 //
FDA
Qilu Pharma`s Generics Bumetanide Receives Approval in US
19 Sep 2024 //
FDA
Qilu Pharmaceutical`s Generics Sugammadex Receives Tentative Approval in US
28 Aug 2024 //
FDA
Qilu`s Generics Meropenem Receives Approval in US
22 Jul 2024 //
FDA
Qilu Pharma`s Generic Cetrorelix Acetate Receives Approval in the U.S
16 Apr 2024 //
FDA
Qilu Pharma Spesolimab-sbzo Receives Suppl Approval in the U.S
19 Mar 2024 //
FDA
Qilu`s Generic Lenalidomide Receives Approval in the U.S.
22 Feb 2024 //
FDA
Qilu`s Generic Gefitinib Receives Approval in the U.S.
13 Feb 2023 //
FDA
Qilu Pharmaceutical`s Generic Imatinib Mesylate Receives Approval in US
21 Jun 2022 //
FDA
Qilu Pharm Generic Pemetrexed Disodium Receives Approval in the U.S.
25 May 2022 //
FDA
Qilu Pharmaceutical Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
Qilu`s Generic Imatinib Mesylate Receives Approval in the U.S.
11 Feb 2022 //
FDA
Qilu Pharm`s Generic Pemetrexed Receives Approval in the U.S.
28 Jan 2022 //
FDA
Qilu`s Generic Decitabine Receives Approval In US
16 Apr 2021 //
FDA
Qilu`s Generic Fosaprepitant Dimeglumine Receives Approval In US
08 Sep 2020 //
FDA
Qilu Pharm`s Generic Exemestane Receives Approval in US
16 Apr 2020 //
FDA
Qilu Pharm`s Generic Tadalafil Receives Approval in US
28 Mar 2019 //
FDA
Qilu Pharm`s Generic Solifenacin Succinate Receives Tentative Approval in US
21 Dec 2018 //
FDA
Qilu Pharm`s Generic Tadalafil Receives Approval in US
08 Nov 2018 //
FDA
Qilu Pharm`s Generic Ceftriaxone Sodium Receives Approval in US
24 Oct 2018 //
FDA
Qilu Pharm`s Generic Cefazolin Sodium Receives Approval in US
24 Oct 2018 //
FDA
Qilu Pharma`s Generic Palonosetron Hydrochloride Receives Approval in US
21 Sep 2018 //
FDA
Qilu Pharm’s Generic Premetrexed Receives Tentative Approval In US
19 May 2017 //
FDA
Qilu Pharm Co Ltd`s Generic Oxaliplatin approved in US as chemotherapy drug
11 May 2016 //
FDA
Qilu Pharm`s Generic Olanzapine approved in US as an atypical antipsychotic
27 Jan 2016 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.